Cost-Effectiveness of Optimizing Use of Statins in Australia: Using Outpatient Data From the REACH Registry

QR Code

Cost-Effectiveness of Optimizing Use of Statins in Australia: Using Outpatient Data From the REACH Registry

Background: Although few cardiovascular registries report the costs of illness or cost-effectiveness of health interventions, such information is critical to inform the effective and cost-effective management of cardiovascular disease, particularly if drawn from population-based registries, which mo...

Full description

Bibliographic Details
Main Authors:	Ademi, Z., Reid, Christopher, Hollingsworth, B., Stoelwinder, J., Steg, P., Bhatt, D., Vale, M., Liew, D.
Format:	Journal Article
Published:	2011
Online Access:	http://hdl.handle.net/20.500.11937/5622

Similar Items

Is It Cost-Effective To Increase Aspirin Use in Outpatient Settings for Primary or Secondary Prevention? Simulation Data from the REACH Registry Australian Cohort
by: Ademi, Z., et al.
Published: (2013)

The impact of lost therapeutic benefit (LTB) in high-risk hypertensive patients: 2-Year follow-up data from the australian REACH registry
by: Ademi, Z., et al.
Published: (2013)

Outcomes from the REACH registry for Australian general practice patients with or at high risk of atherothrombosis
by: Reid, Christopher, et al.
Published: (2012)

Outcomes and excess costs among patients with cardiovascular disease
by: Ademi, Z., et al.
Published: (2013)

Prevalence and Outcomes of Undiagnosed Peripheral Arterial Disease Among High Risk Patients in Australia: An Australian REACH Sub-Study
by: Si, Si, et al.
Published: (2018)

Drug treatment and cost of cardiovascular disease in Australia
by: Ademi, Z., et al.
Published: (2009)

Australians at Risk: Management of Cardiovascular Risk Factors in the REACH Registry
by: Reid, Christopher, et al.
Published: (2008)

Predictors of health care use among patients with or at high risk of atherothrombotic disease: Two-year follow-up data
by: Ademi, Z., et al.
Published: (2014)

Geographic variation and risk factors for systemic and limb ischemic events in patients with symptomatic peripheral artery disease: Insights from the REACH Registry
by: Abtan, J., et al.
Published: (2017)

Does Statin Benefits Patients with Heart Failure Undergoing Percutaneous Coronary Intervention? Findings from the Melbourne Interventional Group Registry
by: Chin, K., et al.
Published: (2018)

Economic implications of obesity among people with atherothrombotic disease
by: Ademi, Z., et al.
Published: (2010)

Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International clarify registry
by: Fauchier, L., et al.
Published: (2015)

Predicting the impact of polypill use in a metabolic syndrome population: An effectiveness and cost-effectiveness analysis
by: Zomer, E., et al.
Published: (2013)

Funding linked to ongoing research: Impact of the bosentan patient registry on pricing in Australia
by: Wlodarczyk, J., et al.
Published: (2011)

Association of genetic polymorphisms and their attributing factors with lipid profiles among outpatient statin users in Hospital USM
by: Shamsudin, Amirul Faez
Published: (2022)

Statins for people at low risk of cardiovascular disease: Authors' reply
by: Zomer, E., et al.
Published: (2012)

Overview of pharmacoeconomic modelling methods
by: Ademi, Z., et al.
Published: (2013)

The Role of Clinical Registries in Monitoring Drug Safety and Efficacy
by: Reid, Christopher
Published: (2015)

Barriers to statin use in the Philippines
by: Feliciano, Katrina T, et al.
Published: (2022)

Improving Guideline Compliance in Australia With a National Percutaneous Coronary Intervention Outcomes Registry
by: Eccleston, D., et al.
Published: (2016)

Cardiovascular readmissions and excess costs following percutaneous coronary intervention in patients with chronic kidney disease: Data from a large multi-centre Australian registry
by: Ariyaratne, T., et al.
Published: (2013)

Characteristics of national and major regional percutaneous coronary intervention registries: A structured literature review
by: Biswas, S., et al.
Published: (2018)

Factors Influencing Prescribing of Statins in Singapore Compared to Queensland, Australia
by: Curran, R., et al.
Published: (2016)

MESOTHELIOMA IN AUSTRALIA-RESULTS FROM THE AUSTRALIAN MESOTHELIOMA REGISTRY
by: Sim, M., et al.
Published: (2016)

Quality Control Activities Associated with Registries in Interventional Cardiology and Surgery
by: Andrianopoulos, N., et al.
Published: (2011)

Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective
by: Zomer, E., et al.
Published: (2018)

Implementing Sustainable Data Collection for a Cardiac Outcomes Registry in an Australian Public Hospital
by: Cox, N., et al.
Published: (2017)

Association of Statin Use With Disability-Free Survival and Cardiovascular Disease Among Healthy Older Adults
by: Zhou, Z., et al.
Published: (2020)

Using Mexican food to reach Malaysians
by: New Straits Times,
Published: (2013)

A new model to evaluate the long-term cost effectiveness of orphan and highly specialised drugs following listing on the Australian Pharmaceutical Benefits Scheme: The Bosentan Patient Registry
by: Owen, A., et al.
Published: (2008)

A PRACTICAL DEFINITION OF LATE STENT THROMBOSIS: INSIGHTS FROM THE MELBOURNE INTERVENTIONAL GROUP REGISTRY
by: Yan, B., et al.
Published: (2011)

Pahang melioidosis registry
by: How, Soon Hin, et al.
Published: (2009)

Pahang meliodosis registry
by: How, Soon Hin, et al.
Published: (2007)

TemporalTrends of Heart Failure Patients Undergoing Percutaneous Coronary Intervention: Findings From Melbourne Interventional Group Registry
by: Chin, K., et al.
Published: (2017)

Using a cardiac arrest registry to measure the quality of emergency medical service care decade of findings from the Victorian Ambulance cardiac arrest registry
by: Nehme, Z., et al.
Published: (2015)

Statins and periodontal inflammation: A pleiotropic effect of statins or a pleiotropic effect of LDL-cholesterol lowering?
by: Norata, Giuseppe, et al.
Published: (2014)

Rescue PCI in the management of STEMI: Contemporary results from the Melbourne Interventional Group registry
by: Fernando, H., et al.
Published: (2021)

Establishment of a Percutaneous Coronary Intervention Registry in Vietnam: Rationale and Methodology
by: Vu, Hoa T. T., et al.
Published: (2020)

Statins: Antimicrobial resistance breakers or makers?
by: Ko, H., et al.
Published: (2017)

Is there potential for repurposing statins as novel antimicrobials?
by: Hennessy, E., et al.
Published: (2016)

Cannot write session to /tmp/vufind_sessions/sess_m5uril8s4taneid978t38i3jvk